NEWS & EVENTS
A new study reveals how spontaneous changes in the molecular characteristics of tumors can lead to tumors with a mixed population of cells requiring treatment with several types of therapeutic drugs. Read more at Mass General News.
Fierce Biotech reports on a nanovaccine developed by NIBIB researchers that could enhance a current cancer immunotherapy approach while reducing side effects. Read more at fiercebiotech.com.
During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells in the heart. But damage doesn't end after the crushing pain subsides. Instead, the heart's walls thin out, the organ becomes enlarged, and scar tissue forms. These changes can cause heart failure. Scientists now report they have developed injectable gels to prevent this damage. Read more and watch the video at ACS News.
In a classic experiment, Ivan Pavlov conditioned dogs to salivate at the ringing of a bell. Now, scientists can see what happens in the brains of live animals during this experiment with a new technique. The approach could lead to a greater understanding of how we learn and develop addictions. Read more at ACS News.
Since its emergence in the 1970s, magnetic resonance imaging (MRI) has given physicians a better look inside tissues, helping to diagnose maladies from brain tumors to internal bleeding to torn ligaments. A new technology creates images resolved enough to enable consistent diagnoses across populations for the first time. Read more and watch the video at PR Newswire.
Researchers have just achieved a spectacular breakthrough in cancer research. They have developed new nanorobotic agents capable of navigating through the bloodstream to administer a drug with precision by specifically targeting the active cancerous cells of tumors. Read more at Polytechnique Montreal News.